|20th April 2015
Blue Latitude’s Head of Customer Experience Elisa del Galdo will discuss User Experience and its Influence on Customer Centricity in Pharma at Camp Digital’s annual event on Thursday 23rd April in Manchester.
In her presentation, Elisa will elaborate on the idiosyncrasies of providing customer experience services to the pharmaceutical and healthcare industry. She will share examples from a variety of Blue Latitude Health projects providing solutions for customer reps, healthcare practitioners, patients and carers. Her talk will explore some of the issues encountered when researching and designing innovative solutions and services in a highly regulated environment.
Elisa said, “I am delighted to be invited to present again this year at Camp Digital. The conference is a great forum to discuss the digital landscape and offers the opportunity to exchange innovative ideas, especially in the highly regulated pharmaceutical sector.” She added,
For more information on Elisa’s presentation, have a look at the Camp Digital website.
To find out more about how the pharma industry can start getting customer experience right, download Blue Latitude’s Customer Experience: The Essential Guide for Pharma.
Elisa’s presentation slides will be made available after the conference on our website.
Elisa has over 20 years of experience as a UX practitioner, working in over 20 countries. Her career has been focused on providing a range of services in research, design, and training. She has a proven track record of, developing, mentoring, and inspiring user experience teams, as well as working with clients to ensure successful engagements.
As Head of Customer Experience at Blue Latitude, Elisa’s focus is on helping client projects benefit from the very best in user-centred design practices and strategic customer experience thinking.
|25th March 2019
March is Myltiple Myeloma Awareness Month, a disease which has personally touched the lives of many people at Blue Latitude. For the rest of the month we have a few events planned to mark our continued commitment to combatting this disease.